Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2759 | TNF-a | 100 | ng/mL | 1 | M-CSF | 1434.0 | 52 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | M-CSF | 964.0 | 52 | |
RA1931 | TNF-a | 100 | ng/mL | 1 | M-CSF | 817.0 | 49 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | M-CSF | 789.0 | 36 | |
N2586 | TNF-a | 100 | ng/mL | 1 | M-CSF | 762.5 | 50 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | M-CSF | 433.0 | 40 | |
RA1869 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | M-CSF | 483.5 | 54 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | M-CSF | 611.0 | 43 | |
N2759 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | M-CSF | 708.0 | 51 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | M-CSF | 568.0 | 45 | |
RA1931 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | M-CSF | 496.0 | 48 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | M-CSF | 524.5 | 46 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | M-CSF | 492.0 | 51 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | M-CSF | 788.0 | 45 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 1 | M-CSF | 760.0 | 55 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | M-CSF | 879.0 | 51 | |
N2759 | IL-1 alpha | 100 | ng/mL | 1 | M-CSF | 942.0 | 44 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | M-CSF | 1124.0 | 51 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 1 | M-CSF | 907.0 | 44 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | M-CSF | 808.0 | 29 | |
N2586 | IL-1 alpha | 100 | ng/mL | 1 | M-CSF | 587.0 | 24 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 280.0 | 31 | |
RA1869 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 349.0 | 39 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 390.0 | 31 | |
N2759 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 449.0 | 49 |